Study of MT-5111 in HER2-positive Solid Tumors
Public ClinicalTrials.gov record NCT04029922. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1 Open-label, Multicenter Dose Escalation and Expansion Study of MT-5111 in Subjects With Previously Treated Advanced HER2-positive Solid Tumors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This will be a Phase 1b, first in human, open-label, dose escalation and expansion study of MT-5111 (a recombinant fusion protein) given as monotherapy in subjects with HER2-positive solid tumors
Study identification
- NCT ID
- NCT04029922
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 12, 2019 (Actual)
- Primary completion
- Feb 1, 2023 (Actual)
- Completion
- Apr 27, 2023 (Actual)
- Last update posted
- Jun 18, 2023
2019 – 2023
United States locations
- U.S. sites
- 23
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic (Arizona) | Phoenix | Arizona | 85054 | — |
| St. Joseph Heritage Healthcare | Fullerton | California | 92835 | — |
| Cancer and Blood Specialty Clinic | Los Alamitos | California | 90720 | — |
| Cedars-Sinai Medical Center | Santa Monica | California | 90048 | — |
| UCLA Hematology & Oncology | Santa Monica | California | 90404 | — |
| Sarah Cannon Research Institute | Denver | Colorado | 80218 | — |
| Sylvester Comprehensive Cancer Center (University of Miami) | Coral Gables | Florida | 33146 | — |
| South Broward Hospital District d/b/a Memorial Healthcare System | Hollywood | Florida | 33021 | — |
| Mayo Clinic (Florida) | Jacksonville | Florida | 32224 | — |
| Orlando Health | Orlando | Florida | 32806 | — |
| South Broward Hospital District d/b/a Memorial Healthcare System | Pembroke Pines | Florida | 33024 | — |
| BRCR Medical Center | Plantation | Florida | 33322 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Mayo Clinic (Minnesota) | Rochester | Minnesota | 55905 | — |
| Washington University | St Louis | Missouri | 63130 | — |
| Novant Health Cancer Institute | Charlotte | North Carolina | 28204 | — |
| Novant Health Forsyth Medical Center | Winston-Salem | North Carolina | 27103 | — |
| Prisma Health | Greenville | South Carolina | 29605 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| Mary Crowley Cancer Research | Dallas | Texas | 75251 | — |
| The University of Texas Health Science Center | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04029922, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04029922 live on ClinicalTrials.gov.